Global Maltose Excipient Market Growth 2023-2029
The global Maltose Excipient market size is projected to grow from US$ 426.5 million in 2022 to US$ 642 million in 2029; it is expected to grow at a CAGR of 6.0% from 2023 to 2029.
United States market for Maltose Excipient is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Maltose Excipient is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Maltose Excipient is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Maltose Excipient players cover Nagase, Pfanstiehl, ITW Reagents, MP Biomedical, DMS Pharmaceutical, Bio Basic, MilliporeSigma, HiMedia and Cargill, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Maltose (IUPAC name: 4-O-(α-d-glucopyranosyl)-β-d-glucopyranose) is a disaccharide pharmaceutical excipient consisting of two molecules of Glucose linked by an α-(1,4′) glycosidic bond. It occurs naturally in germinating seeds, hence the alternative names, Malt sugar and Maltibiose.
LPI (LP Information)' newest research report, the “Maltose Excipient Industry Forecast” looks at past sales and reviews total world Maltose Excipient sales in 2022, providing a comprehensive analysis by region and market sector of projected Maltose Excipient sales for 2023 through 2029. With Maltose Excipient sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Maltose Excipient industry.
This Insight Report provides a comprehensive analysis of the global Maltose Excipient landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Maltose Excipient portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Maltose Excipient market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Maltose Excipient and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Maltose Excipient.
This report presents a comprehensive overview, market shares, and growth opportunities of Maltose Excipient market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Maltose Powder
Maltose Solution
Segmentation by application
Nutrition Infusion
Drug Stabilizer
Blood Separation
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Nagase
Pfanstiehl
ITW Reagents
MP Biomedical
DMS Pharmaceutical
Bio Basic
MilliporeSigma
HiMedia
Cargill
SPI Pharma
Spectrum Chemical
Thermo Scientific Chemicals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Maltose Excipient market?
What factors are driving Maltose Excipient market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Maltose Excipient market opportunities vary by end market size?
How does Maltose Excipient break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please note: The report will take approximately 2 business days to prepare and deliver.